Mylan Pharmaceuticals recalls

12 official recalls and safety alerts involving Mylan Pharmaceuticals since 2022-01, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Mylan Pharmaceuticals or the relevant agency.

  1. 2026-09-09
  2. US
    Drugs & medicalClass II

    Mylan Pharmaceuticals Inc recalls Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505,…

    Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria

    FDA · DrugMylan Pharmaceuticals IncNationwide within the U.SOfficial notice →
  3. US
  4. 2026-08-26
  5. US
  6. 2026-08-05
  7. US
  8. 2026-03-11
  9. US
    Drugs & medicalClass II

    MYLAN PHARMACEUTICALS INC recalls Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: Mylan…

    Failed Dissolution Specifications

    FDA · DrugMYLAN PHARMACEUTICALS INCNationwide within the United StatesOfficial notice →
  10. 2025-03-26
  11. US
    Drugs & medicalClass II

    MYLAN PHARMACEUTICALS INC recalls Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC…

    Failed Dissolution Specifications - low dissolution results

    FDA · DrugMYLAN PHARMACEUTICALS INCUS Nationwide.Official notice →
  12. 2022-08-03
  13. US
    Drugs & medicalClass I

    Mylan Pharmaceuticals Inc recalls Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons…

    Labeling: Missing label: Label missing from some prefilled pens.

    FDA · DrugMylan Pharmaceuticals IncProduct was distributed nationwide within the United StatesOfficial notice →
  14. 2022-05-04
  15. US
  16. 2022-04-27
  17. US
    Drugs & medicalClass II

    Mylan Pharmaceuticals Inc recalls Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505…

    Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.

    FDA · DrugMylan Pharmaceuticals IncNationwide in the USAOfficial notice →
  18. 2022-04-13
  19. US
    Drugs & medicalClass II

    Mylan Pharmaceuticals Inc recalls Travoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV…

    Subpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related substance impurities/degradation during routine…

    FDA · DrugMylan Pharmaceuticals IncNationwide in the USA and Puerto RicoOfficial notice →
  20. 2022-02-02
  21. US
    Drugs & medicalClass II

    Mylan Pharmaceuticals Inc recalls Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol, 10 g aerosol containers, Rx Only,…

    cGMP deficiencies

    FDA · DrugMylan Pharmaceuticals IncRecalled product was distributed nationwide within the United States.Official notice →
  22. 2022-01-26
  23. US
    Drugs & medicalClass I

    Mylan Pharmaceuticals Inc recalls Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pen (NDC 49502-0196-71), packaged in Five 3 mL Prefilled…

    Labeling: Missing Label: label missing from some Semglee prefilled pens.

    FDA · DrugMylan Pharmaceuticals IncNationwide in the USA and Thailand.Official notice →